These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD. Starr A; Sattler R Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960 [TBL] [Abstract][Full Text] [Related]
4. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Saberi S; Stauffer JE; Jiang J; Garcia SD; Taylor AE; Schulte D; Ohkubo T; Schloffman CL; Maldonado M; Baughn M; Rodriguez MJ; Pizzo D; Cleveland D; Ravits J Acta Neuropathol; 2018 Mar; 135(3):459-474. PubMed ID: 29196813 [TBL] [Abstract][Full Text] [Related]
5. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration. Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573 [TBL] [Abstract][Full Text] [Related]
6. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels. Beckers J; Tharkeshwar AK; Van Damme P Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058 [TBL] [Abstract][Full Text] [Related]
7. DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD. Fu X; Zhang Z; Hayes LR; Wright N; Asbury J; Li S; Ye Y; Sun S Exp Neurol; 2024 Jun; 376():114768. PubMed ID: 38556190 [TBL] [Abstract][Full Text] [Related]
8. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene. Wen X; Westergard T; Pasinelli P; Trotti D Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540 [TBL] [Abstract][Full Text] [Related]
9. C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation. Licata NV; Cristofani R; Salomonsson S; Wilson KM; Kempthorne L; Vaizoglu D; D'Agostino VG; Pollini D; Loffredo R; Pancher M; Adami V; Bellosta P; Ratti A; Viero G; Quattrone A; Isaacs AM; Poletti A; Provenzani A EMBO J; 2022 Jan; 41(1):e105026. PubMed ID: 34791698 [TBL] [Abstract][Full Text] [Related]
10. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons. Lopez-Gonzalez R; Lu Y; Gendron TF; Karydas A; Tran H; Yang D; Petrucelli L; Miller BL; Almeida S; Gao FB Neuron; 2016 Oct; 92(2):383-391. PubMed ID: 27720481 [TBL] [Abstract][Full Text] [Related]
11. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Farg MA; Konopka A; Soo KY; Ito D; Atkin JD Hum Mol Genet; 2017 Aug; 26(15):2882-2896. PubMed ID: 28481984 [TBL] [Abstract][Full Text] [Related]
12. The nuclear ubiquitin ligase adaptor SPOP is a conserved regulator of C9orf72 dipeptide toxicity. Snoznik C; Medvedeva V; Mojsilovic-Petrovic J; Rudich P; Oosten J; Kalb RG; Lamitina T Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34593637 [TBL] [Abstract][Full Text] [Related]
14. Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients. Yin S; Lopez-Gonzalez R; Kunz RC; Gangopadhyay J; Borufka C; Gygi SP; Gao FB; Reed R Cell Rep; 2017 Jun; 19(11):2244-2256. PubMed ID: 28614712 [TBL] [Abstract][Full Text] [Related]
15. Repeat-associated non-AUG translation in C9orf72-ALS/FTD is driven by neuronal excitation and stress. Westergard T; McAvoy K; Russell K; Wen X; Pang Y; Morris B; Pasinelli P; Trotti D; Haeusler A EMBO Mol Med; 2019 Feb; 11(2):. PubMed ID: 30617154 [TBL] [Abstract][Full Text] [Related]
16. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Jovičić A; Mertens J; Boeynaems S; Bogaert E; Chai N; Yamada SB; Paul JW; Sun S; Herdy JR; Bieri G; Kramer NJ; Gage FH; Van Den Bosch L; Robberecht W; Gitler AD Nat Neurosci; 2015 Sep; 18(9):1226-9. PubMed ID: 26308983 [TBL] [Abstract][Full Text] [Related]
17. Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS/FTD. Odeh HM; Shorter J Emerg Top Life Sci; 2020 Dec; 4(3):293-305. PubMed ID: 32639008 [TBL] [Abstract][Full Text] [Related]
18. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis. Trageser KJ; Yang EJ; Smith C; Iban-Arias R; Oguchi T; Sebastian-Valverde M; Iqbal UH; Wu H; Estill M; Al Rahim M; Raval U; Herman FJ; Zhang YJ; Petrucelli L; Pasinetti GM Mol Neurobiol; 2023 Jul; 60(7):4004-4016. PubMed ID: 37010807 [TBL] [Abstract][Full Text] [Related]
19. Insights into C9ORF72-Related ALS/FTD from Drosophila and iPSC Models. Yuva-Aydemir Y; Almeida S; Gao FB Trends Neurosci; 2018 Jul; 41(7):457-469. PubMed ID: 29729808 [TBL] [Abstract][Full Text] [Related]
20. C9orf72-associated dipeptide protein repeats form A11-positive oligomers in amyotrophic lateral sclerosis and frontotemporal dementia. Bhatt N; Puangmalai N; Sengupta U; Jerez C; Kidd M; Gandhi S; Kayed R J Biol Chem; 2024 Feb; 300(2):105628. PubMed ID: 38295729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]